Logo
E

Elucidata

222 employees

Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.

Basic info

Industry

software development

Sectors

Biotechnology
Artificial Intelligence
Life Science
Data Integration
FAIR Data
Drug Discovery
Biomedical Data
Software
Health Care
Analytical Pipelines
Clinical Trials
Single Cell Data
Bioinformatics
Drug Targets
Life Sciences
SaaS
Analytics
Automated Curation
Clinical Omics Data
Bulk RNA-Seq Data
Machine Learning

Date founded

2015

Funding rounds raised

Total raised

$16M

from 6 investors over 6 rounds

E

Elucidata raised $16M on September 27, 2022

Investors: Hyperplane Venture Capital, IvyCap Ventures Advisors Private Limited and F-Prime Capital Partners

E

Elucidata raised $5M on January 28, 2021

Investors: IvyCap Ventures Advisors Private Limited and Hyperplane Venture Capital

E

Elucidata raised $1.7M on June 18, 2018

Investors: Hyperplane Venture Capital

FAQ